0001542869-22-000001.txt : 20221028 0001542869-22-000001.hdr.sgml : 20221028 20221028120832 ACCESSION NUMBER: 0001542869-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221028 DATE AS OF CHANGE: 20221028 EFFECTIVENESS DATE: 20221028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trice Medical, Inc. CENTRAL INDEX KEY: 0001542869 IRS NUMBER: 454037098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-463129 FILM NUMBER: 221340022 BUSINESS ADDRESS: STREET 1: 40 GENERAL WARREN BOULEVARD SUITE 100 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-989-8080 MAIL ADDRESS: STREET 1: 40 GENERAL WARREN BOULEVARD SUITE 100 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: InSyte Medical Technologies, Inc. DATE OF NAME CHANGE: 20120221 D 1 primary_doc.xml X0708 D LIVE 0001542869 Trice Medical, Inc. 40 GENERAL WARREN BOULEVARD SUITE 100 MALVERN PA PENNSYLVANIA 19355 610-989-8080 DELAWARE InSyte Medical Technologies, Inc. Corporation true MARK FOSTER C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Executive Officer Director ALAN DAVIS C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Director ERIC C. SALZMAN C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Director RANDY SCOTT C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Director VASANT PADMANABHAN C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Director MICHAEL SCHRAUBEN C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Director CHRIS YAMAMOTO C/O TRICE MEDICAL, INC. 40 GENERAL WARREN BOULEVARD, SUITE 100 MALVERN PA PENNSYLVANIA 19355 Director Other Health Care Decline to Disclose 06b false 2022-10-15 false true true Equity issued to certain former stockholders of Tenex Health, Inc. as earnout consideration pursuant to the underlying Agreement and Plan of Merger dated March 31, 2021. 0 7296615 7296615 0 The above amount is the aggregate dollar value of all of the equity issued to certain former stockholders of Tenex Health, Inc. No new capital was received by Trice Medical, Inc. in connection with such issuance. true 7 209 0 0 0 false Trice Medical, Inc. Mark Foster Mark Foster Chief Executive Officer 2022-10-28